Different inhibitory effects of 5-S-glutathionyl-beta-alanyl-L-dopa (5-S-GA-L-D) analogues on autophosphorylation and substrate phosphorylation of Src protein tyrosine kinase
Zb. Zheng et al., Different inhibitory effects of 5-S-glutathionyl-beta-alanyl-L-dopa (5-S-GA-L-D) analogues on autophosphorylation and substrate phosphorylation of Src protein tyrosine kinase, CHEM PHARM, 47(1), 1999, pp. 136-137
Starting with 5-S-glutathionyl-beta-alanyl-L-dopa (1) and 5- S-glutathionyl
-beta-alanyl-dopamine (2), a series of analogues with truncated glutathiony
l and beta-alanyl-dopa moieties were synthesized, and their inhibitory effe
cts on autophosphorylation and substrate phosphorylation reaction by c-Src
and by epidermal growth factor receptor (EGFR) were evaluated. When the glu
tamyl residue was removed, the inhibitory effects on v-Src autophosphorylat
ion decreased about 4- to 5-fold, and concomitant removal of the glutamyl a
nd beta-alanyl residues resulted in a 40- to 60-fold decrease in the inhibi
tion of v-Src autophosphorylation, On the other hand, these modifications h
ad little effect on the inhibitory activity of substrate (Raytide(TM)) phos
phorylation by c-Src, Interestingly, 5-S-cysteinyl dopamine inhibited the S
rc substrate phosphorylation reaction with comparable potency to that of ge
nistein, Nonpeptide lipophilic derivatives had a similar inhibition on v-Sr
c autophosphorylation but decreased inhibitory effects on substrate phospho
rylation when compared to the lead compounds. Most compounds showed little
effect on substrate phosphorylation by EGFR.